IBHA SEDENU: Open Payments
NPI 1467701177 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 38 payments from 10 companies in 2025. Trend: 2023 $2,873 · 2024 $1,566 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $355 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $167 |
| Tris Pharma Inc | 4 | $94 |
| ABBVIE INC. | 5 | $84 |
| Almatica Pharma LLC | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $51 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Auvelity, CAPLYTA, Dyanavel XR, VRAYLAR, LOREEV XR, HETLIOZ, REXULTI, Qelbree.
Industry payments across FL — which companies pay providers there.
